Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Fi nal 12 month results of a randomised, open-label trial

The Lancet

Volumn 382, Issue 9905, 2013, Pages 1638-1645

  Thiele, Holger ^a   Zeymer, Uwe ^b   Neumann, Franz Josef ^c   Ferenc, Miroslaw ^d   Olbrich, Hans Georg ^d   Hausleiter, Jörg ^e   De Waha, Antoinette ^f   Richardt, Gert ^g   Hennersdorf, Marcus ^h   Empen, Klaus ⁱ   Fuernau, Georg ^a   Desch, Steffen ^a   Eitel, Ingo ^a   Hambrecht, Rainer ^j   Lauer, Bernward ^k   Böhm, Michael ^l   Ebelt, Henning ^m   Schneider, Steffen ^b   Werdan, Karl ^m   Schuler, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Asklepios Clinic Langen Seligenstadt   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g Heart Center Segeberger Kliniken   (Germany)

^h SLK Kliniken Heilbronn   (Germany)

ⁱ UNIVERSITY OF GREIFSWALD   (Germany)

^j Klinikum Links der Weser   (Germany)

^k ZENTRALKLINIK BAD BERKA   (Germany)

^l SAARLAND UNIVERSITY   (Germany)

^m MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; LEVOSIMENDAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANXIETY DISORDER; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CONTROLLED STUDY; COUNTERPULSATION; DAILY LIFE ACTIVITY; DEATH; DEFIBRILLATOR; DEPRESSION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; INTRAAORTIC BALLOON PUMP; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SELF CARE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVOR; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84887618830     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61783-3     Document Type: Article

References (30)

1. Aissaoui N, Puymirat E, Tabone X., et al Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French Nationwide Registries. Eur Heart J 2012; 33: 2535-43.
2. Goldberg RJ, Spencer FA, Gore J.M., Lessard D., Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009; 119: 1211-19.
3. Hochman JS, Sleeper LA, Webb J.G., et al Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625-34.
4. Jeger RV, Radovanovic D, Hunziker P.R., et al Ten-year incidence and treatment of cardiogenic shock. Ann Intern Med 2008; 149: 618-26.
5. Thiele H, Allam B, Chatellier G., Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010; 31: 1828-35.
6. Scheidt S, Wilner G, Mueller H., et al Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973; 288: 979-84.
7. Sjauw KD, Engstrom AE, Vis M.M., et al A systematic review and meta-analysis of intra aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30: 459-68.
8. O'Gara P.T., Kushner FG, Ascheim D.D., et al 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362-425.
9. Steg PG, James SK, Atar D, et al ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.
10. Wijns W, Kolh P, Danchin N., et al Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-55.
11. Thiele H, Zeymer U, Neumann F-J, et al Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-96.
12. Hochman JS, Sleeper LA, Webb J.G., et al Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511-15.
13. Hochman JS, Sleeper LA, White H.D., et al One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190-92.
14. Thiele H, Schuler G, Neumann F-J, et al Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012; 163: 938-45.
15. Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment-a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012; 109: 343-51.
16. Thygesen K, Alpert JS, Jaffe AS, et al Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-67.
17. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
18. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
19. Prondzinsky R, Lemm H, Swyter M., et al Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock-the prospective, randomized IABP SHOCK Trial for attenuation of multi-organ dysfunction syndrome. Crit Care Med 2010; 38: 152-60.
20. Prondzinsky R, Unverzagt S, Russ M., et al Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012; 37: 378-84.
21. Fincke R, Hochman JS, Lowe A.M., et al Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004; 44: 340-48.
22. Ohman EM, Nanas J, Stomel R.J., et al Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005; 19: 33-39.
23. Abdel-Wahab M., Saad M, Kynast J., et al Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010; 105: 967-71.
24. Cheng JM, van Leeuwen MA, de Boer SP, et al. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 2013; published online July 3. DOI:10.1016/j.ijcard. 2013.06.009.
25. Greiner W, Claes C, Busschbach J.J., von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005; 6: 124-30.
26. Patel MR, Smalling R W, Thiele H, et al Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI Randomized Trial. JAMA 2011; 306: 1329-37.
27. Katz JN, Stebbins AL, Alexander J.H., et al Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 2009; 158: 680-67.
28. Sleeper LA, Reynolds HR, White H.D., Webb JG, Dzavík V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010; 160: 443-50.
29. Sutton AG, Finn P, Hall J.A., Harcombe AA, Wright RA, de Belder MA. Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart 2005; 91: 339-44.
30. Zeymer U, Vogt A, Zahn R., et al Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Eur Heart J 2004; 25: 322-28.